Similar articles

• The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.

  Branconnier RJ. Branconnier RJ. Psychopharmacol Bull. 1983 Spring;19(2):212-9. Psychopharmacol Bull. 1983. PMID: 6408682 Review. No abstract available.
• Some strategies for tackling the problems of senile dementia and related disorders within the next decade.

  Roth M. Roth M. Dan Med Bull. 1985 Feb;32 Suppl 1:92-111. Dan Med Bull. 1985. PMID: 2859150 No abstract available.
• [New aspects of senile and presenile dementia].

  Seitelberger F. Seitelberger F. Wien Klin Wochenschr Suppl. 1986;170:28-32. Wien Klin Wochenschr Suppl. 1986. PMID: 2880426 German.
• [Regional cerebral blood flow and brain atrophy in senile dementia of Alzheimer type compared to multi-infarct dementia and aged controls].

  Okada K, Kobayashi S, Yamaguchi S, Kitani M, Tsunematsu T. Okada K, et al. Rinsho Shinkeigaku. 1987 May;27(5):545-51. Rinsho Shinkeigaku. 1987. PMID: 3621750 Japanese. No abstract available.
• Critical review of clinical trials in senile dementia--I.

  Orgogozo JM, Spiegel R. Orgogozo JM, et al. Postgrad Med J. 1987 Apr;63(738):237-40. doi: 10.1136/pgmj.63.738.237. Postgrad Med J. 1987. PMID: 2891126 Free PMC article. Review. No abstract available.